Kaluga Regional Clinical Oncology Center
Kaluga, Russian Federation
Medical center in Kaluga
Ulitsa Vishnevskogo, 2, Kaluga, Kaluga Oblast, 248007
About Kaluga Regional Clinical Oncology Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Eli Lilly and Company
1
Loxo Oncology, Inc.
1
Mabscale, LLC
1
MelanomaPRO, Russia
1
OmicsWay Corp.
1
Takeda
1
mAbxience Research S.L.
1
Clinical Trials at Kaluga Regional Clinical Oncology Center
During the past decade, Kaluga Regional Clinical Oncology Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on
average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
2018-02-06
2020-02-27
Completed
627
Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy
2017-10-17
2022-11-01
Active, not recruiting
200
A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation
2019-05-31
2022-12-08
Completed
2,000
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
2019-12-30
2026-12-02
Active, not recruiting
1,068
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
2020-02-17
2027-07-01
Active, not recruiting
250
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
2020-12-21
2026-11-15
Recruiting
815
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
2021-10-04
2027-08-31
Recruiting
860
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kaluga Regional Clinical Oncology Center" #1 sponsor was "Pfizer" with 2 trials, followed by "Eli Lilly and Company" with 1 trials
sponsored, "Loxo Oncology, Inc." with 1 trials sponsored, "Mabscale, LLC" with 1 trials sponsored and "MelanomaPRO, Russia"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kaluga Regional Clinical Oncology Center"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Crocus Medical B.V." with 1 trials as a collaborator, "Kaluga Regional Clinical Oncology Center" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Multidisciplinary medical holding SM-Clinic" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Kaluga Regional Clinical Oncology Center
According to Clinical.Site data, the most researched conditions in "Kaluga Regional Clinical Oncology Center" are
"Non-Small Cell Lung Cancer" (2 trials), "BRAF V600 Mutation" (1 trials), "Breast Neoplasms" (1 trials), "Cancer" (1 trials) and "Cutaneous Melanoma, Stage IV" (1 trials). Many other conditions were trialed in "Kaluga Regional Clinical Oncology Center" in a lesser frequency.
Clinical Trials Intervention Types at Kaluga Regional Clinical Oncology Center
Most popular intervention types in "Kaluga Regional Clinical Oncology Center" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (3 trials), "Bevacizumab" (2 trials), "Paclitaxel" (2 trials), "5-FU" (1 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kaluga Regional Clinical Oncology Center
The vast majority of trials in "Kaluga Regional Clinical Oncology Center" are
9 trials for "All" genders.
Clinical Trials Status at Kaluga Regional Clinical Oncology Center
Currently, there are NaN active trials in "Kaluga Regional Clinical Oncology Center".
undefined are not yet recruiting,
2 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Kaluga Regional Clinical Oncology Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kaluga Regional Clinical Oncology Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Kaluga Regional Clinical Oncology Center
Kaluga Regional Clinical Oncology Center has several departments that took part in Clinical trials: "Kaluga Regional Oncology Center" - 2 trials
Departments List
Name
City
Trials